Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

LRRC69 Inhibitors

LRRC69 Inhibitors comprise a diverse range of compounds that can interact with and modulate the activity of the protein LRRC69. These inhibitors display various chemical structures and properties, each strategically designed to influence the activity of LRRC69 through specific mechanisms. Their modes of action can include direct binding to the protein, altering its structural conformation, affecting its enzymatic activity, or disrupting its interaction with other cellular molecules. The diversity of these mechanisms reflects the complex nature of protein functions and the intricacy of cellular biochemical networks.

Developing and studying these inhibitors involves significant scientific efforts, integrating aspects of molecular biology, chemistry, and computational biology. Researchers use advanced computational methods to model the protein structure and predict potential binding sites for inhibitors. The synthesis of these molecules uses sophisticated techniques in synthetic chemistry, aiming to create compounds ranging from small, targeted molecules to larger, more complex structures. Experimental validation, including biochemical assays and cellular studies, is crucial to determine the actual impact of these inhibitors on the protein's function. This research not only contributes to understanding the specific protein but also enhances broader knowledge in cellular biochemistry and molecular biology.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$150.00
$388.00
113
(4)

Kinase inhibitor, can disrupt phosphorylation processes potentially involving LRRC69.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

PI3K inhibitor, can impact the PI3K/Akt signaling pathway, potentially affecting LRRC69.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

mTOR inhibitor, can influence cell growth and autophagy, potentially impacting LRRC69.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

HDAC inhibitor, can modify gene expression and chromatin structure, potentially affecting LRRC69.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

MAPK/ERK pathway inhibitor, can alter cell signaling processes involving LRRC69.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

p38 MAPK inhibitor, can disrupt stress response and inflammation, potentially linked to LRRC69.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

JNK inhibitor, can alter stress response and apoptosis, potentially involving LRRC69.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

PI3K inhibitor, can disrupt various signaling pathways potentially linked to LRRC69.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$132.00
$1064.00
115
(2)

Proteasome inhibitor, can influence protein degradation, potentially impacting LRRC69.

Nifedipine

21829-25-4sc-3589
sc-3589A
1 g
5 g
$58.00
$170.00
15
(1)

Calcium channel blocker, can alter calcium signaling, potentially affecting LRRC69.